SCS vs URGN

Comparison between Steelcase Inc - Class A (SCS, Company) and UroGen Pharma Ltd (URGN, Company).

SCS is from the Consumer Cyclical sector, while URGN is from the Healthcare sector.

5-Year PerformanceURGN has outperformed SCS, delivering a return of +19.8% compared to +7.7%

SCS vs URGN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SCS(COMPANY)	URGN(COMPANY)
Market Cap	$1.85B	$1.85B
Max Drawdown	81.28%	93.98%
Sharpe Ratio	0.56	1.88
5Y Beta	N/A	1.19
Industry	Furnishings, Fixtures & Appliances	Biotechnology
P/E Ratio	19.34	-13.44
Forward P/E	13.12	N/A
PEG Ratio	N/A	-0.09
Dividend Yield	2.48%	N/A
5Y Dividends CAGR	-0.73%	N/A
5Y EPS CAGR	-6.81%	-11.74%
Debt to Equity	44.02%	-152.54%
Free Cash Flow Yield	-2.01%	-8.98%
P/S Ratio	N/A	13.16
P/B Ratio	N/A	19.27

Market Cap

Winner

SCS

$1.85B

URGN

$1.85B

Max Drawdown

Winner

SCS

81.28%

URGN

93.98%

Sharpe Ratio

SCS

0.56

Winner

URGN

1.88

5Y Beta

SCS

N/A

URGN

1.19

Industry

SCS

Furnishings, Fixtures & Appliances

URGN

Biotechnology

P/E Ratio

SCS

19.34

Winner

URGN

-13.44

Forward P/E

SCS

13.12

URGN

N/A

PEG Ratio

SCS

N/A

URGN

-0.09

Dividend Yield

SCS

2.48%

URGN

N/A

5Y Dividends CAGR

SCS

-0.73%

URGN

N/A

5Y EPS CAGR

Winner

SCS

-6.81%

URGN

-11.74%

Debt to Equity

SCS

44.02%

Winner

URGN

-152.54%

Free Cash Flow Yield

Winner

SCS

-2.01%

URGN

-8.98%

P/S Ratio

SCS

N/A

URGN

13.16

P/B Ratio

SCS

N/A

URGN

19.27

SCS vs URGN - Historical Returns

Returns include dividend reinvestment.

Period	SCS	URGN
1 month	+2.54%	+43.26%
3 months	-3.82%	+102.02%
6 months	+55.01%	+67.42%
1 year	+23.97%	+193.36%
5 years(CAGR)	+7.74%	+19.75%
10 years(CAGR)	+2.01%	+11.54%
Max(CAGR)	+4.57%	+11.54%

SCS

+2.54%

Winner

URGN

+43.26%

SCS

-3.82%

Winner

URGN

+102.02%

SCS

+55.01%

Winner

URGN

+67.42%

SCS

+23.97%

Winner

URGN

+193.36%

5Y(CAGR)

SCS

+7.74%

Winner

URGN

+19.75%

10Y(CAGR)

SCS

+2.01%

Winner

URGN

+11.54%

Max(CAGR)

SCS

+4.57%

Winner

URGN

+11.54%

SCS vs URGN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	SCS	URGN
2026	N/A	+67.42%
2025	+41.90%	+118.88%
2024	-7.47%	-29.98%
2023	+90.63%	+73.61%
2022	-37.26%	-8.84%
2021	-4.17%	-47.14%
2020	-31.32%	-44.67%
2019	+40.87%	-25.03%
2018	+0.83%	+11.44%
2017	-11.21%	+166.17%
2016	+30.36%	N/A
2015	-14.87%	N/A
2014	+19.96%	N/A
2013	+25.61%	N/A
2012	+71.67%	N/A
2011	-28.18%	N/A
2010	+61.20%	N/A
2009	+12.88%	N/A
2008	-63.54%	N/A
2007	-0.24%	N/A
2006	+18.97%	N/A
2005	+22.01%	N/A
2004	-1.84%	N/A
2003	+33.21%	N/A
2002	-20.92%	N/A
2001	+10.96%	N/A
2000	+21.92%	N/A
1999	-5.45%	N/A

SCS vs URGN Drawdown Comparison

The maximum drawdown for SCS was -77.27%, occurring on Mar 9, 2009. Recovery took 1440 trading sessions.

The maximum drawdown for URGN was -93.98%, occurring on May 27, 2025. This drawdown has not yet recovered.

The current SCS drawdown is -8.18%. The current URGN drawdown is -41.80%.

Rank	SCS	URGN
#1	-77.27% Jun 14, 2007 - Mar 5, 2013	-93.98% May 18, 2018 - May 27, 2025
#2	-68.21% Dec 18, 2019 - Dec 19, 2022	-20.07% May 30, 2017 - Jun 26, 2017
#3	-50.89% Mar 15, 2002 - Jan 10, 2006	-18.48% Jan 25, 2018 - Mar 5, 2018
#4	-41.68% Dec 1, 2015 - Sep 21, 2018	-16.63% Sep 14, 2017 - Nov 2, 2017
#5	-35.83% Aug 14, 2000 - Mar 15, 2002	-15.97% Mar 14, 2018 - Apr 3, 2018
#6	-30.31% May 5, 2006 - Jan 10, 2007	-14.93% Nov 13, 2017 - Jan 3, 2018
#7	-25.23% Sep 21, 2018 - Sep 23, 2019	-13.38% Jun 27, 2017 - Aug 30, 2017
#8	-24.14% Nov 4, 1999 - Jun 7, 2000	-11.40% Apr 4, 2018 - May 18, 2018
#9	-20.42% Mar 14, 2013 - Jul 11, 2013	-5.75% Jan 16, 2018 - Jan 22, 2018
#10	-17.17% Oct 29, 2013 - Apr 16, 2014	-4.09% May 16, 2017 - May 18, 2017
#11	-16.70% Mar 23, 2015 - Nov 25, 2015	-3.88% Jan 3, 2018 - Jan 16, 2018
#12	-14.71% Jun 23, 2014 - Oct 30, 2014	-3.19% May 11, 2017 - May 15, 2017
#13	-11.27% Dec 30, 2014 - Feb 23, 2015	-2.61% Mar 9, 2018 - Mar 14, 2018
#14	-10.77% Oct 2, 2013 - Oct 29, 2013	-2.59% May 22, 2017 - May 30, 2017
#15	-9.18% Jul 19, 2013 - Sep 20, 2013	-2.21% Sep 7, 2017 - Sep 12, 2017